Great Lakes Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-233,958
Closed -$2.06M 864
2023
Q4
$2.06M Buy
233,958
+11,881
+5% +$104K 0.02% 455
2023
Q3
$2.55M Buy
222,077
+26,787
+14% +$307K 0.02% 429
2023
Q2
$4.94M Sell
195,290
-104,611
-35% -$2.65M 0.05% 328
2023
Q1
$9.66M Buy
+299,901
New +$9.66M 0.09% 225